Vornado Realty Trust (NYSE: VNO) reported today: Quarter Ended December 31, 2024 Financial Results NET INCOME attributable to common shareholders for the quarter ended December 31, 2024 was $1,203,000 ...

During the recent period, Arrowhead (ARWR) signed and closed a potentially transformational licensing and collaboration agreement with Sarepta ...

TD Cowen had upgraded Merck in early 2024 based on confidence in Keytruda and Gardasil’s performance, a lack of binary risks, and an attractive valuation. However, setbacks in Gardasil’s China sales ...